What is the ticker symbol for Shionogi & Co.?

Shionogi & Co. trades as 4507.T on the TSE.

What are Shionogi & Co.'s marketed drugs?

Top marketed products include Fetroja, Ulesfia, Keflex, Doribax, Cuvposa.

TSE 5 marketed · 7 in Phase 3

Ticker	4507.T (TSE)

Fetroja · Infectious Disease · revenue 300
Fetroja works by binding to penicillin-binding proteins on bacterial cell walls, inhibiting cell wall synthesis and ultimately leading to bacterial cell death.
Ulesfia · Dermatology
Keflex · Metabolic
Doribax · Infectious Disease
Cuvposa · Metabolic
Cuvposa works by blocking the action of a chemical called acetylcholine, which stimulates the muscarinic receptors in the body.

Nonhormonal vaginal lubricant · Women's Health
Nonhormonal vaginal lubricant works by providing moisture to the vagina to reduce friction and discomfort during sexual intercourse.
Oral Glycopyrrolate Liquid · Respiratory
Glycopyrrolate is an anticholinergic medication that works by blocking the action of acetylcholine, a neurotransmitter that stimulates the parasympathetic nervous system, thereby reducing secretions and slowing the heart rate.
Ospemifene (Dose 1) · Women's Health / Gynecology
Ospemifene is a selective estrogen receptor modulator (SERM) that acts as an estrogen agonist in vaginal tissue to treat moderate to severe dyspareunia caused by genitourinary syndrome of menopause.
Placebo to Baloxavir Marboxil · Infectious Disease / Virology
Baloxavir marboxil is a cap-dependent endonuclease inhibitor that blocks influenza virus polymerase, preventing viral mRNA synthesis and replication.
Pravafen · Other
S-217622 · Diabetes
S-217622 is a small molecule that targets the SGLT2 receptor.
S-268019-b · Gastroenterology
S-268019-b is a selective serotonin 5-HT4 receptor partial agonist that enhances gastric motility and accelerates gastric emptying.

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: